• Solid financial performance in 2025 with 9.3% growth in proportional EBITDA
• Established clear distribution policy and capital allocation framework
• Rejected unsolicited takeover offer from IFM as too low and opportunistic
• Focused on executing strategy to generate long-term value for investors

Atlas Arteria's Chair Debbie Goodin and CEO Hugh Wehby addressed the company's 2026 Annual General Meetings, highlighting the significant progress achieved across the business in 2025. The company delivered strong financial results, with toll revenue growth and a 9.3% increase in proportional EBITDA despite the impact of a temporary supplemental tax in France. Atlas Arteria also introduced greater clarity for investors on its approach to capital allocation, establishing a clear distribution policy and a Capital Allocation Framework. The company provided 2026 distribution guidance of 40 cents per security and confirmed its target to maintain distributions of at least 40 cents per security. Goodin emphasized that optimizing the performance of Atlas Arteria's existing businesses remains a key priority, and the company's strategy is the foundation from which future investor returns will be generated. Regarding the unsolicited takeover offer from IFM, the Independent Directors unanimously recommended that investors reject the offer, stating it is too low, opportunistic and highly conditional. Wehby reflected on Atlas Arteria's key strengths, including its performance-driven culture, strong partnerships, and portfolio resilience, and outlined the company's strategic priorities to optimize business performance and drive growth.